These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8590572)

  • 1. Relationships between conformational behaviour and binding affinity towards beta 1 and beta 2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents.
    Villa L; Villa AM; Pallavicini M; Romeo S; Valoti E; Ferri V; Iuliano E; Brunello N
    Farmaco; 1995 Oct; 50(10):643-58. PubMed ID: 8590572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CoMFA analysis of the human beta(1)-adrenoceptor binding affinity of a series of phenoxypropanolamines.
    Louis SN; Rezmann-Vitti LA; Nero TL; Iakovidis D; Jackman GP; Louis WJ
    Eur J Med Chem; 2002 Feb; 37(2):111-25. PubMed ID: 11858844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 4-(1-oxo-isoindoline) and 4-(5,6-dimethoxy-1-oxo-isoindoline)-substituted phenoxypropanolamines and their beta1-, beta2-adrenergic receptor binding studies.
    Jindal DP; Singh B; Coumar MS; Bruni G; Massarelli P
    Bioorg Chem; 2005 Aug; 33(4):310-24. PubMed ID: 15975623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro evaluation of derivatives of the β₁-adrenergic receptor antagonist HX-CH 44.
    Stephenson KA; Wilson AA; Houle S; Vasdev N
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5506-9. PubMed ID: 21783363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.
    Blanc M; Tamir A; Aubriot S; Michel MC; Bouzoubaa M; Leclerc G; Demenge P
    J Med Chem; 1998 May; 41(10):1613-8. PubMed ID: 9572886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
    Ahmed M; Hanaoka Y; Nagatomo T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines.
    Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Fryer AD; Melarange RA; Shivdasani C
    J Med Chem; 1983 Nov; 26(11):1570-6. PubMed ID: 6138435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bovine beta 3-adrenergic agonistic activities of a novel series of aryloxypropanolamines.
    el Hadri A; Nicolle E; Guillaume MC; Leclerc G; Pietri-Rouxel F; Strosberg AD; Archimbault P
    Pharmazie; 2001 Jul; 56(7):517-22. PubMed ID: 11487967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
    Adejare A; Deal SA; Day MS
    Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and beta-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives.
    Gentili D; Lapucci A; Macchia B; Macchia M; Martinelli A; Nencetti S; Orlandini E; Ferni G; Pinza M
    Farmaco; 1995; 50(7-8):519-26. PubMed ID: 7669190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of plasma membrane beta-adrenoceptors in rat hearts using the tissue segment binding method.
    Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Muramatsu I
    Life Sci; 2006 Aug; 79(10):941-8. PubMed ID: 16725159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling, design, chiral aspects and role of para-substituents in aryloxypropranolamine based beta-blockers.
    Nandel FS; Dhaliwal RK; Singh B
    Indian J Biochem Biophys; 1999 Feb; 36(1):29-35. PubMed ID: 10549157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, binding affinity and selectivity of new beta 1- and beta 2-adrenoceptor blockers.
    Brizzi V; Francioli M; Brufani M; Filocamo L; Bruni G; Massarelli P
    Farmaco; 1999; 54(11-12):713-20. PubMed ID: 10668169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional models for agonist and antagonist complexes with beta 2 adrenergic receptor.
    Kontoyianni M; DeWeese C; Penzotti JE; Lybrand TP
    J Med Chem; 1996 Oct; 39(22):4406-20. PubMed ID: 8893835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient asymmetric synthesis of the potent beta-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activity.
    Baker JR; Hothersall JD; Fitzmaurice RJ; Tucknott M; Vinter A; Tinker A; Caddick S
    Chem Commun (Camb); 2010 Jun; 46(22):3953-4. PubMed ID: 20431838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacodynamic study on clenbuterol-induced toxicity: beta1- and beta2-adrenoceptors involvement in guinea-pig tachycardia in an in vitro model.
    Mazzanti G; Di Sotto A; Daniele C; Battinelli L; Brambilla G; Fiori M; Loizzo S; Loizzo A
    Food Chem Toxicol; 2007 Sep; 45(9):1694-9. PubMed ID: 17449161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure-activity relationships of halogenated phenylethanolamine and phenoxypropanolamine].
    Bercher H; Grisk A
    Acta Biol Med Ger; 1976; 35(1):79-85. PubMed ID: 10706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.